Smoking intensity and implant- and patient-related variables may increase risk of peri-implantitis

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-10 14:30 GMT   |   Update On 2023-09-10 14:30 GMT

Smoking intensity and implant- and patient-related variables linked to increased risk of peri-implantitis suggests a new study published in the Clinical Oral Implants Research.A study was done to determine the association between tobacco and peri-implant diseases in a sample of patients who had received implant-supported restorations in a university dental clinic. Furthermore, the study aimed...

Login or Register to read the full article

Smoking intensity and implant- and patient-related variables linked to increased risk of peri-implantitis suggests a new study published in the Clinical Oral Implants Research.

A study was done to determine the association between tobacco and peri-implant diseases in a sample of patients who had received implant-supported restorations in a university dental clinic. Furthermore, the study aimed to investigate patient- and implant-related variables associated with peri-implant diseases.

The present retrospective study analyzed data from 117 patients treated with implant-supported restorations from 2001 to 2013. A total of 450 implants were evaluated. Patients were selected from an electronic database, and patient- and implant-related variables were evaluated. Detailed information regarding the smoking history (i.e., smoking status, lifetime cumulative dose, duration of exposure, intensity of the habit, and smoking cessation) was recorded. The primary study outcome was peri-implant status [i.e., health (H), peri-implant mucositis (PM) and peri-implantitis (PI)]. Univariate and multinomial regression models comparing PM and PI versus peri-implant health were conducted.

Results

A total of 117 subjects [55 (47%) females and 62 (53%) males] with a mean age at examination of 64.2 years (SD 11.6) and rehabilitated with 450 implants were included. The average number of implants per patient was 4.6 (SD 3.3) with a mean time in function of 8.0 years (SD 1.9). Fifty-six patients (47.9%) were non-smokers, 42 (35.9%) were former-smokers, and 19 (16.2%) were current-smokers. Thirty-nine subjects (33.4%) were H, whereas 41 (35%) and 37 (31.6%) exhibited PM and PI, respectively. At implant level, the corresponding values were 142 (31.6%), 230 (51.1%) and 78 (17.3%). In the multinomial regression model, significant associations for peri-implant diseases were observed for the mean number of implants per patient (p = .016), function time (p = .048), implants placed simultaneously with guided bone regeneration (p = .016), implant surface (p = .020), keratinized mucosa at the buccal aspect (p = .032), and access to interproximal hygiene (p < .001). In addition, ever smokers >23 pack-years exhibited a significantly higher risk for peri-implantitis (p = .002). Finally, the multinomial regression analysis revealed that subjects who had stopped smoking more than 21 years before the last examination presented a significantly lower risk of peri-implant diseases than a smoking cessation of ≤21 years (p = .028).

Smoke intensity was associated with an increased risk of the development of peri-implantitis. Moreover, the risk of peri-implant diseases might be similar in those subjects who had stopped smoking for more than 21 years with respect to never-smokers.

Reference:

Martinez-Amargant, J., de Tapia, B., Pascual, A., Takamoli, J., Esquinas, C., Nart, J., & Valles, C. (2023). Association between smoking and peri-implant diseases: A retrospective study. Clinical Oral Implants Research, 00, 1–14. https://doi.org/10.1111/clr.14147

Keywords:

Smoking, intensity, implant, patient-related, variables, linked, increased risk, peri-implantitis, Martinez-Amargant, J., de Tapia, B., Pascual, A., Takamoli, J., Esquinas, C., Nart, J., & Valles, C, Clinical Oral Implants Research

Tags:    
Article Source : Clinical Oral Implants Research

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News